ZW14985A1 - Antigens of plasmodium falciparum - Google Patents

Antigens of plasmodium falciparum

Info

Publication number
ZW14985A1
ZW14985A1 ZW149/85A ZW14985A ZW14985A1 ZW 14985 A1 ZW14985 A1 ZW 14985A1 ZW 149/85 A ZW149/85 A ZW 149/85A ZW 14985 A ZW14985 A ZW 14985A ZW 14985 A1 ZW14985 A1 ZW 14985A1
Authority
ZW
Zimbabwe
Prior art keywords
antigens
plasmodium falciparum
falciparum
plasmodium
Prior art date
Application number
ZW149/85A
Other languages
English (en)
Inventor
James Kemp David
Leon Coppel Ross
Bryce Saint Robert
Edward Bianco Albert
Fredric Anders Robin
Vallancey Brown Graham
Frederick Cowman Alan
Frank Mitchell Graham
Original Assignee
Inst Medical W & E Hall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Medical W & E Hall filed Critical Inst Medical W & E Hall
Publication of ZW14985A1 publication Critical patent/ZW14985A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • A61K39/015Hemosporidia antigens, e.g. Plasmodium antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZW149/85A 1984-09-11 1985-09-11 Antigens of plasmodium falciparum ZW14985A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPG706784 1984-09-11
AUPG706684 1984-09-11

Publications (1)

Publication Number Publication Date
ZW14985A1 true ZW14985A1 (en) 1986-01-29

Family

ID=25642846

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW149/85A ZW14985A1 (en) 1984-09-11 1985-09-11 Antigens of plasmodium falciparum

Country Status (13)

Country Link
EP (1) EP0193586B1 (de)
JP (1) JPH0698773A (de)
AU (1) AU599305B2 (de)
CA (1) CA1340213C (de)
DE (1) DE3587503T2 (de)
GB (1) GB2176191B (de)
HK (1) HK132693A (de)
IL (1) IL76338A (de)
MY (1) MY102593A (de)
OA (1) OA08325A (de)
SG (2) SG65089G (de)
WO (1) WO1986001802A1 (de)
ZW (1) ZW14985A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003724A1 (en) * 1984-02-21 1985-08-29 National Research Development Corporation Improvements in or relating to the production of malaria vaccines
AU606042B2 (en) * 1985-12-24 1991-01-31 Saramane Pty Ltd Asexual blood stage antigens of plasmodium falciparum
WO1987003882A1 (en) * 1985-12-24 1987-07-02 The Walter And Eliza Hall Institute Of Medical Res Asexual blood stage antigens of plasmodium falciparum
WO1987005607A1 (en) * 1986-03-14 1987-09-24 Saramane Pty. Ltd.; Polypeptides providing protective immunity against malaria
EP0261248B1 (de) * 1986-03-20 1991-05-29 Sawai Pharmaceutical Co., Ltd. -g(a), -g(a)-trehalose trimycolat und arzneimittelzubereitung
IT1213576B (it) * 1986-12-23 1989-12-20 Eniricerche Spa Composizione polipeptidica utile per la preparazione di vaccini antimalaria e di kits diagnostici per la determinazione di anticorpi antimerozoite.
FR2672290B1 (fr) 1991-02-05 1995-04-21 Pasteur Institut Sequences peptidiques specifiques des stades hepatiques de p. falciparum porteuses d'epitopes capables de stimuler les lymphocytes t.
US5532133A (en) * 1993-06-02 1996-07-02 New York University Plasmodium vivax blood stage antigens, PvESP-1, antibodies, and diagnostic assays

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
GB8404378D0 (en) * 1984-02-20 1984-03-28 Biogen Nv Dna sequence recombinant dna molecules
DK79985A (da) * 1984-02-22 1985-08-23 Wellcome Found Kloning af dna for protozoelle antigener og dets anvendelse
WO1986004922A1 (en) * 1985-02-20 1986-08-28 Memorial Sloan-Kettering Cancer Center cDNA CODING FOR PLASMODIUM FALCIPARUM GLYCOPHORIN BINDING PROTEINS WEIGHING 130,000 DALTONS AND 155,000 DALTONS

Also Published As

Publication number Publication date
GB2176191A (en) 1986-12-17
WO1986001802A1 (en) 1986-03-27
SG65089G (en) 1990-01-26
EP0193586A4 (de) 1988-03-22
JPH0698773A (ja) 1994-04-12
HK132693A (en) 1993-12-10
DE3587503D1 (en) 1993-09-09
EP0193586A1 (de) 1986-09-10
AU599305B2 (en) 1990-07-19
IL76338A (en) 1994-08-26
CA1340213C (en) 1998-12-15
SG119293G (en) 1994-01-21
GB2176191B (en) 1989-06-01
OA08325A (en) 1988-02-29
GB8610243D0 (en) 1986-05-29
MY102593A (en) 1992-08-17
DE3587503T2 (de) 1993-11-25
EP0193586B1 (de) 1993-08-04
AU4732685A (en) 1986-03-20

Similar Documents

Publication Publication Date Title
SG48314A1 (en) Improved antibodies to plasmodium falciparum
DE3571613D1 (en) Preparation of (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols
GB8424104D0 (en) P falciparum
AU557570B2 (en) Antigen from parasite of plasmodium
GB2096893B (en) Antigens from parasites of the genus plasmodium
GB2099300B (en) Antigens from parasites of the genus plasmodium
NZ215034A (en) Production of plasmodium falciparum cs protein
PH22185A (en) Treatment of malaria
GB2176191B (en) Antigens of plasmodium falciparum
ZA869671B (en) Asexual blood stage antigens of plasmodium falciparum
ZW8386A1 (en) Highly repetitive antigens of plasmodium falciparum
ZA856960B (en) Antigens of plasmodium falciparum
DE3566540D1 (en) Preparation of fluoropyridines
AU6687786A (en) Asexual blood stage antigens of plasmodium falciparum
GB8916546D0 (en) Rhoptry antigen of plasmodium falciparum
GB2200642B (en) Small molecular weight antigen of plasmodium falciparum
AU7699887A (en) Merozoite surface antigen of plasmodium falciparum
ZA862732B (en) Highly repetitive antigens of plasmodium falciparum
GB2200641B (en) Merozoite surface antigen of plasmodium falciparum
ZA875266B (en) Merozoite surface antigen of plasmodium falciparum
NZ221114A (en) Merozoite surface antigen of plasmodium falciparum
GB8404493D0 (en) Malaria vaccines
GB8428643D0 (en) Production of malaria vaccines
GB8432337D0 (en) Production of malaria vaccines
ZA875265B (en) Small molecular weight antigen of plasmodium falciparum